Rxsight Financial Statements From 2010 to 2024

RXST Stock  USD 46.88  0.48  1.03%   
Rxsight financial statements provide useful quarterly and yearly information to potential Rxsight investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Rxsight financial statements helps investors assess Rxsight's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Rxsight's valuation are summarized below:
Gross Profit
21.3 M
Profit Margin
(0.24)
Market Capitalization
1.9 B
Enterprise Value Revenue
12.8168
Revenue
128.3 M
There are currently one hundred twenty trending fundamental ratios for Rxsight that can be evaluated and compared over time across competitors. All traders should check out Rxsight's recent fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Rxsight Total Revenue

93.53 Million

Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 18.9 K, Net Interest Income of 3.4 M or Interest Income of 6.9 M, as well as many indicators such as Price To Sales Ratio of 14.82, Dividend Yield of 0.0 or PTB Ratio of 9.1. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
  
Check out the analysis of Rxsight Correlation against competitors.
For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Rxsight Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets162 M182.6 M126.2 M
Slightly volatile
Short and Long Term Debt Total2.9 MM12.1 M
Slightly volatile
Other Current Liabilities9.3 M13.2 M6.4 M
Slightly volatile
Total Current Liabilities15.2 M20.9 M10.7 M
Slightly volatile
Other Liabilities130.6 M123.2 M170.8 M
Slightly volatile
Property Plant And Equipment Net12.9 M13.3 M17.8 M
Slightly volatile
Current Deferred Revenue1.1 MM619.4 K
Slightly volatile
Accounts Payable2.5 M3.9 M2.3 M
Pretty Stable
Cash14.9 M9.7 M10.3 M
Slightly volatile
Non Current Assets Total13.7 M14.1 M18.8 M
Slightly volatile
Non Currrent Assets Other274.8 K147 K168.2 K
Slightly volatile
Other Assets1.1 M1.8 MM
Slightly volatile
Cash And Short Term Investments119.2 M127.2 M92.5 M
Slightly volatile
Net Receivables21.3 M20.3 M4.5 M
Slightly volatile
Common Stock Total Equity23.9 K25.2 K43 M
Slightly volatile
Common Stock Shares Outstanding31.8 M34.5 M28.3 M
Slightly volatile
Short Term Investments104.3 M117.5 M82.2 M
Slightly volatile
Liabilities And Stockholders Equity162 M182.6 M126.2 M
Slightly volatile
Non Current Liabilities Total1.2 M1.3 M302.8 M
Slightly volatile
Capital Lease ObligationsMM5.2 M
Slightly volatile
Inventory12.3 M17.4 M8.9 M
Slightly volatile
Other Current Assets3.9 M3.5 M2.3 M
Slightly volatile
Total Liabilities21.1 M22.2 M313.8 M
Slightly volatile
Property Plant And Equipment Gross21.9 M36 M19.6 M
Pretty Stable
Total Current Assets143.2 M168.4 M107.1 M
Slightly volatile
Capital Stock34.2 K36 K43 M
Slightly volatile
Net Working Capital128 M147.5 M96.4 M
Slightly volatile
Short Term Debt2.4 M1.8 M1.5 M
Slightly volatile
Common Stock34.2 K36 K43 M
Slightly volatile
Property Plant Equipment11.8 M9.1 M16.9 M
Slightly volatile
Long Term Debt39.6 M46.2 M29.2 M
Slightly volatile
Long Term Debt Total34.7 M39.1 M42.5 M
Slightly volatile
Capital Surpluse689.4 M731.4 M631.1 M
Slightly volatile
Non Current Liabilities Other59.2 K66.6 K72.5 K
Slightly volatile

Rxsight Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision18.9 K20 K23.5 K
Pretty Stable
Interest Income6.9 M6.6 M2.6 M
Slightly volatile
Depreciation And Amortization4.4 M4.2 MM
Slightly volatile
Interest Expense2.7 M3.3 MM
Slightly volatile
Selling General Administrative43.3 M74.8 M25.1 M
Slightly volatile
Total Revenue93.5 M89.1 M19.4 M
Slightly volatile
Other Operating Expenses93.7 M139.2 M63.9 M
Slightly volatile
Research Development28.8 M29.1 M28.4 M
Slightly volatile
Cost Of Revenue21.6 M35.3 M10.4 M
Slightly volatile
Total Operating Expenses72.1 M103.8 M53.5 M
Slightly volatile
Reconciled Depreciation4.4 M4.2 MM
Slightly volatile
Income Tax Expense18.9 K20 K23.5 K
Pretty Stable
Non Operating Income Net Other1.7 M1.4 M2.5 M
Slightly volatile

Rxsight Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation9.6 M15.7 M6.3 M
Slightly volatile
Begin Period Cash Flow18.4 M12.6 M41.3 M
Slightly volatile
Depreciation4.4 M4.2 MM
Slightly volatile
Capital Expenditures3.5 M4.8 M3.7 M
Slightly volatile
Total Cash From Financing Activities51 M61.5 M19.6 M
Slightly volatile
End Period Cash Flow15.7 M10.4 M11.1 M
Slightly volatile
Dividends Paid514.4 K578.7 K630.1 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio14.8215.5958137
Slightly volatile
Days Sales Outstanding97.4683.103113
Slightly volatile
Stock Based Compensation To Revenue0.170.17681.4478
Slightly volatile
Capex To Depreciation0.621.13460.9244
Slightly volatile
EV To Sales14.7415.5208136
Slightly volatile
Inventory Turnover1.322.0270.9768
Slightly volatile
Days Of Inventory On Hand312180505
Slightly volatile
Payables Turnover7.019.14114.4948
Slightly volatile
Research And Ddevelopement To Revenue0.310.32619.046
Slightly volatile
Capex To Revenue0.05130.0541.2431
Slightly volatile
Cash Per Share3.03.69123.2025
Slightly volatile
Days Payables Outstanding74.3339.9296146
Slightly volatile
Current Ratio10.888.056610.4227
Pretty Stable
Receivables Turnover3.444.39213.3652
Slightly volatile
Graham Number19.5612.154627.4319
Slightly volatile
Capex Per Share0.120.13970.1325
Slightly volatile
Revenue Per Share2.712.58530.6157
Slightly volatile
Interest Debt Per Share0.09120.0960.2963
Slightly volatile
Debt To Assets0.20.250.2407
Pretty Stable
Operating Cycle410263618
Slightly volatile
Days Of Payables Outstanding74.3339.9296146
Slightly volatile
Quick Ratio10.017.22329.5867
Pretty Stable
Net Income Per E B T0.81.00040.9864
Slightly volatile
Cash Ratio0.440.46370.9604
Very volatile
Cash Conversion Cycle336223472
Slightly volatile
Days Of Inventory Outstanding312180505
Slightly volatile
Days Of Sales Outstanding97.4683.103113
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.181.11571.0972
Very volatile
Fixed Asset Turnover7.046.70511.3757
Slightly volatile
Debt Ratio0.20.250.2407
Pretty Stable
Price Sales Ratio14.8215.5958137
Slightly volatile
Asset Turnover0.510.4880.1194
Slightly volatile

Rxsight Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.5 B1.4 B459.5 M
Slightly volatile
Enterprise Value1.5 B1.4 B477.3 M
Slightly volatile

Rxsight Fundamental Market Drivers

Forward Price Earnings86.2069
Cash And Short Term Investments127.2 M

Rxsight Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Rxsight Financial Statements

Rxsight shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred RevenueM1.1 M
Total Revenue89.1 M93.5 M
Cost Of Revenue35.3 M21.6 M
Stock Based Compensation To Revenue 0.18  0.17 
Research And Ddevelopement To Revenue 0.33  0.31 
Capex To Revenue 0.05  0.05 
Revenue Per Share 2.59  2.71 
Ebit Per Revenue(0.56)(0.59)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.